会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Novel N'-acylated phenyl-hydrazine and hydrozone derivatives
    • 新型N {40-酰基苯基 - 肼和水解产物
    • US3974145A
    • 1976-08-10
    • US439035
    • 1974-02-04
    • Michio KimuraShigeho InabaHisao Yamamoto
    • Michio KimuraShigeho InabaHisao Yamamoto
    • C07D209/60C07D209/70C07D307/54C07D317/66C07D317/68C07D319/18
    • C07D307/54C07D209/60C07D209/70C07D317/66C07D317/68C07D319/18
    • Novel indolylacetic acid derivatives, which have excellent anti-inflammatory, antipyretic and analgesic activities, represented by the formula, ##SPC1##Wherein X.sub.1 and X.sub.2 each is a member selected from the group consisting of oxygen and methylene; A is a member selected from the group consisting of unsubstituted saturated hydrocarbon chain having up to 5 carbon atoms, unsubstituted unsaturated hydrocarbon chain having up to 5 carbon atoms and substituted saturated or substituted ethylenically unsaturated hydrocarbon chain having up to 5 carbon atoms, in which the substituents are selected from the group consisting of halogen or phenyl, the hydrocarbon chain being straight or blanched one; m is 0 or 1; n is 1 or 2; R.sub.1 and R.sub.2 each is a member selected from the group consisting of hydrogen and alkyl having up to 4 carbon atoms; R.sub.3 is a member selected from the group consisting of alkyl having up to 4 carbon atoms, unsubstituted or a lower alkyl-, lower alkoxy-, lower alkylthio-, nitro-, cyano-, methylenedioxy-, ethylenedioxy- or halogen-substituted aryl, each of said alkyl, alkoxy and alkylthio substituents containing up to 4 carbon atoms, or unsubstituted, or halogen-, alkyl- or phenyl-substituted or benzene ring-condensed, saturated or unsaturated mono- or poly-aclicyclic group, or alkyl group substituted by said alicyclic group, or unsubstituted or methyl-, ethyl- or halogen-substituted 5- or 6-membered heterocyclic ring group containing oxygen, sulfur or nitrogen atom; R.sub.4 is a member selected from the group consisting of alkyl having up to 4 carbon atoms or hydrogen, or a group of M (wherein M is a cation).The indolylacetic acid of the formula (I) is prepared by reacting a compound of the formula, ##SPC2##Wherein X.sub.1, X.sub.2 and n are the same as defined above and B is a member selected from the group consisting of ##EQU1## and Z (wherein Z is a nitrogen protecting system comprising at least one readily removable group), with an acid halide represented by the formula,R.sub.3 --(A).sub.m --CO--hal (V)wherein R.sub.3, A and m are the same as defined above and hal is halogen, to obtain N.sup.1 -acylated compound of the formula, ##SPC3##Wherein X.sub.1, X.sub.2, R.sub.3, A, B, m and n are the same as defined above, then reacting the resultant N.sup.1 -acylated compound (II) with an aliphatic acid derivative represented by the formula, ##EQU2## wherein R.sub.1, R.sub.2 and R.sub.4 are the same as defined above.
    • 新型吲哚乙酸衍生物,其具有优异的抗炎,解热和止痛活性,由式WHEREIN X1和X2各自为选自氧和亚甲基的成员; A是选自具有至多5个碳原子的未取代的饱和烃链,具有至多5个碳原子的未取代的不饱和烃链和具有至多5个碳原子的取代的饱和或取代的烯属不饱和烃链的成员,其中 取代基选自卤素或苯基,烃链是直链或漂白的; m为0或1; n为1或2; R1和R2各自是选自氢和具有至多4个碳原子的烷基的成员; R3是选自具有至多4个碳原子的烷基,未取代的或低级烷基,低级烷氧基 - ,低级烷硫基 - ,硝基 - ,氰基 - ,亚甲二氧基 - ,亚乙二氧基或卤素取代的芳基的成员, 所述烷基,烷氧基和烷硫基取代基含有至多4个碳原子,或未取代的或卤素,烷基或苯基取代的或苯环稠合的饱和或不饱和的单 - 或多 - 酰基基团或烷基取代的 或含有氧,硫或氮原子的未取代或甲基,乙基或卤素取代的5元或6元杂环基; R4是选自具有至多4个碳原子的烷基或氢的成员,或一组M(其中M是阳离子)。
    • 5. 发明授权
    • Novel cyclopropylmethylamine derivatives
    • 新型环丙基甲胺衍生物
    • US4103030A
    • 1978-07-25
    • US635331
    • 1975-11-26
    • Atsuyuki KojimaYoshito KamenoJunki KatsubeShigeho InabaHisao Yamamoto
    • Atsuyuki KojimaYoshito KamenoJunki KatsubeShigeho InabaHisao Yamamoto
    • A61K31/13A61K31/135A01N9/20A01N9/24C07C91/16C07C91/28
    • Novel cyclopropylmethylamine compounds of the formula: ##STR1## wherein Ar.sup.1 represents a phenyl group having one or more substituents selected from the group consisting of halogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy and trifluoromethyl, of which at least one is present at the o- or m-position, Ar.sup.2 represents an unsubstituted phenyl group or a phenyl group substituted with one or more substituents selected from the group consisting of halogen and C.sub.1 -C.sub.4 alkyl, R represents hydrogen, C.sub.1 -C.sub.4 alkyl or C.sub.2 -C.sub.4 hydroxyalkyl and R' represents C.sub.1 -C.sub.4 alkyl or C.sub.2 -C.sub.4 hydroxyalkyl, and their non-toxic salts, which possess various useful pharmacological activities and can be produced by reduction of the corresponding compounds of the formula: ##STR2## wherein Ar.sup.1, Ar.sup.2, R and R' are each as defined above or by condensation of the corresponding compounds of the formula: ##STR3## wherein Ar.sup.1 and Ar.sup.2 are each as defined above and X is a conventional leaving (removable) group with amines of the formula: ##STR4## wherein R and R' are each as defined above.
    • 新的下式的环丙基甲胺化合物:其中Ar 1表示具有一个或多个选自卤素,C 1 -C 4烷基,C 1 -C 4烷氧基和三氟甲基的取代基的苯基,其中至少一个存在于 或位置,Ar 2表示未取代的苯基或被一个或多个选自卤素和C 1 -C 4烷基的取代基取代的苯基,R表示氢,C 1 -C 4烷基或C 2 -C 4羟烷基, R'表示C1-C4烷基或C2-C4羟基烷基及其无毒盐,它们具有各种有用的药理活性,可以通过还原相应的下式化合物来制备:其中Ar1,Ar2,R和 R'各自如上所定义,或通过下式的相应化合物的缩合:其中Ar 1和Ar 2各自如上所定义,X是具有下式的胺的常规离去(可除去)基团:其中 R和R'各自如上所定义。
    • 10. 发明授权
    • Fused quinazolinones and a process for production thereof
    • 熔融喹唑啉酮及其制备方法
    • US3980645A
    • 1976-09-14
    • US521768
    • 1974-11-07
    • Shigeho InabaMichihiro YamamotoKikuo IshizumiKazuo MoriMasao KoshibaHisao Yamamoto
    • Shigeho InabaMichihiro YamamotoKikuo IshizumiKazuo MoriMasao KoshibaHisao Yamamoto
    • C07D487/04C07D498/04C07D265/00C07D273/00C07D295/00
    • C07D487/04
    • Fused quinazolinone derivatives of the formula, ##SPC1##Wherein R.sub.1 and R.sub.2 are individually hydrogen, C.sub.1.sub.-4 alkyl, C.sub.1.sub.-4 alkoxy, nitro, C.sub.1.sub.-4 alkylsulfonyl or halogen; R.sub.3 is pyridyl, thienyl or a group of the formula ##SPC2##Wherein R.sub. 4 is hydrogen or halogen; R is hydrogen, C.sub.1.sub.-4 alkyl, C.sub.2.sub.-5 alkenyl, aralkyl, (C.sub.3.sub.-6 cycloalkyl)C.sub.1.sub.-4 alkyl, (C.sub.1.sub.-4 alkoxy)C.sub.1.sub.-4 alkyl, (C.sub.1.sub.-4 alkylthio)C.sub.1.sub.-4 alkyl, hydroxy-C.sub.1.sub.-4 alkyl or C.sub.2.sub.-5 alkanoyloxy-C.sub.1.sub.-4 alkyl; Y is oxygen, or a group of the formula N - R.sub.5, wherein R.sub.5 is hydrogen or C.sub.1.sub.-4 alkyl; and Z is C.sub.2.sub.-5 alkylene or alkenylene, are prepared by reacting a trihaloacetamidophenyl ketone derivative of the formula, ##SPC3##Wherein R.sub.1, R.sub.2, R.sub. 3 and R are as defined above; and X.sub.1, X.sub.2 and X.sub.3 are halogen, with an amine of the formula, HY - Z - NH.sub.2, wherein Y and Z are as defined above, or a salt thereof, in the presence of a solvent or a mixture thereof. They have remarkable pharmacological properties such as anti-inflammatory, analgesic and/or uricosuric activities.
    • 下式的稠合喹唑啉酮衍生物WHEREIN R1和R2分别为氢,C1-4烷基,C1-4烷氧基,硝基,C1-4烷基磺酰基或卤素; R 3是吡啶基,噻吩基或式WHEREIN R 4是氢或卤素的基团; R为氢,C 1-4烷基,C 2-5烯基,芳烷基,(C 3-6环烷基)C 1-4烷基,(C 1-4烷氧基)C 1-4烷基,(C 1-4烷硫基)C 1-4烷基,羟基 C 1-4烷基或C 2-5烷酰氧基-C 1-4烷基; Y为氧,或式为N-R5的基团,其中R5为氢或C1-4烷基; Z是C2-5亚烷基或亚烯基,是通过下式的三卤代乙酰胺基苯基酮衍生物WHEREIN R1,R2,R3和R如上所定义而制备的; 并且X 1,X 2和X 3是卤素,在溶剂或其混合物的存在下,与下式的胺HY-Z-NH 2(其中Y和Z如上定义)或其盐。 它们具有显着的药理学性质,如抗炎,镇痛和/或尿酸活性。